Business Wire

Ingram Micro Extends Financing Programs and Flexible Credit Options to Technology Channel Partners across Europe

20.5.2020 09:00:00 EEST | Business Wire | Press release

Share

Ingram Micro Inc. today announced another wave of financial services to help channel partners solve for the cash crunch created by the COVID-19 pandemic, while meeting the technology needs of businesses and consumers worldwide. Readily available throughout Europe, the new and enhanced Ingram Micro Financial Solutions offerings include flexible, low-interest and long-term financing solutions, as well as extended credit terms, deferred payments, as-a-service models and pay-as-you-go options.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200519006025/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Mark Snider, Executive Vice President and Group President, EMEA, Ingram Micro (Photo: Business Wire)

“Ingram Micro is generating new ways to help our channel partners, and the businesses they serve, stay strong, agile and fiscally smart, so they can come out of this crisis in a position of strength,” said Mark Snider, Executive Vice President and Group President, EMEA, Ingram Micro. “Each country throughout Europe is unique, yet many of our channel partners, and their business customers, face similar fiscal and cash flow concerns, due to the economic impact of COVID-19. Fortunately, financial services are one of the many areas where Ingram Micro is clearly differentiated and able to help our channel partners at scale locally and globally.”

In addition, Ingram Micro is also helping channel partners identify and address the European marketplace’s work from home (WFH) and distance learning requirements, as well as cybersecurity-as-a-service, data centre solutions and cloud-based services. “COVID-19 prioritized digital transformation overnight, placing Ingram Micro and our channel partners in a position to serve and help keep the world securely connected and moving forward together,” Snider continued.

John Mayer, Vice President, Channel Financing, Ingram Micro Europe and Asia Pacific adds, “Our financing options are structured to address the present and give businesses a way to prepare for the future—helping our channel partners and the businesses they serve to create and preserve cash, protect credit lines, and align payments to the current business environment, until business activity is more stable and growing.”

Throughout Europe, channel partners are taking advantage of the new Ingram Micro Financial Solutions programs including the purchase and lease back of IT solutions. “Having the flexibility to lease, buy or defer payments is changing the conversation and allowing us to get our customers the technology they need in real-time without taking on the financial risk or using our own cash to close the deal,” says Ingram Micro channel partner Brian Dunleavy, Commercial Director, Viadex UK Ltd.

Channel partners in Europe can also access longer-term financing solutions through IMFS. These solutions will align payments with revised budget objectives and places the needed capital quickly back into business cash reserves. Similarly, Ingram Micro’s “as a service” finance offerings are making it easier for channel partners interested in expanding their managed services business and cloud practices.

“As-a-service financing solutions are easier on budgets, versus capital-intensive one-time technology purchases. This model also establishes a more profitable recurring revenue stream for channel partners,” says Kris Mees, Vice President Finance and International CFO, Ingram Micro Europe. “With the rising adoption of cloud and managed services, we expect our “as-a-service” financing options to gain more traction, and we’re ready to give channel partners, and the businesses they serve the support they need.”

Additionally, Ingram Micro credit and financial experts are working one-on-one with qualified channel partners across Europe to determine what other offerings may be available to them including custom financing solutions and additional credit capacity. Ingram Micro Europe’s standard suite of financial services and solutions includes:

  • Traditional leasing
  • Advanced solutions financing
  • Managed services financing
  • Private-label agreements
  • And, financial structures such as fair market value, full pay out, technology equipment rentals, pay-as-you-grow solutions, and guaranteed purchase options

“Today and every day, helping our channel partners understand the financing options available to them and their customers is equally as important as helping them decide on what technology solutions and services are best suited for the needs of their customers,” concludes Mayer. “Together with our channel partners, we will continue to grow and create sustainable business value that leads to an exceptional experience for them and their customers.”

Ingram Micro Financial Solutions operates globally offering financial programs and services across the Americas, Asia Pacific and Europe. To find out more about the financial solutions in Europe, please contact: https://financing.ingrammicro.eu/.

About Ingram Micro

Ingram Micro helps businesses realize the promise of technology. It delivers a full spectrum of global technology and supply chain services to businesses around the world. Deep expertise in technology solutions, mobility, cloud, and supply chain solutions enables its business partners to operate efficiently and successfully in the markets they serve. Unparalleled agility, deep market insights and the trust and dependability that come from decades of proven relationships, set Ingram Micro apart and ahead. Discover how Ingram Micro can help you realize the promise of technology. More at www.ingrammicro.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Marie Rourke
WhiteFox Marketing Inc.
marie@whitefoxpr.com
714-292-2199

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 11:15:00 EEST | Press release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 20:42:00 EEST | Press release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 17:19:00 EEST | Press release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 17:15:00 EEST | Press release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 16:00:00 EEST | Press release

inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye